Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens

Diabetes Care

Volumn 23, Issue 8, 2000, Pages 1137-1142

  Rosenstock, Julio ^a   Park, Glen ^a   Zimmerman, Joyce ^a  

^a DALLAS DIABETES AND ENDOCRINE CENTER AT MEDICAL CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN GLARGINE; ISOPHANE INSULIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033865137     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.8.1137     Document Type: Article

References (15)

1. Insulin therapy and its shortcomings: The need for new approaches
2. Insulin analogues
3. Pharmacokinetics and pharmacodynamics of insulin: Relevance to the therapy of diabetes mellitus
4. Clinical pharmacology of human insulin
5. Insulin pharmacokinetics
6. Pharmacokinetic considerations of new insulin formulations and routes of absorption
7. Insulin formulation and delivery
8. The new era of biotech insulin analogues
9. Frontiers of clinical research in type I diabetes
10. New insulin preparations with prolonged action profiles: A21-modified arginine insulins
11. Controlling insulin bioavailability by crystal contract engineering
12. Comparison of the pharmacokinetics/dynamics of Gly(A21)-Arg(B31,B32)-human-insulin (HOE71GT) with NPH-insulin following subcutaneous injection by using euglycaemic clamp technique
13. Efficacy of HOE 901 following subcutaneous injection for four days in type I diabetic subjects
14. Efficacy and safety of HOE 901 versus NPH insulin in patients with tpye 1 diabetes
15. Effectiveness of human ultralente versus NPH insulin in providing basal insulin replacement for an insulin lispro multiple daily injection regimen: A double-blind randomized prospective trial